Medtronic (MDT) Common Equity (2013 - 2026)

Medtronic's Common Equity history runs 14 years deep, the most recent figure standing at $49.0 billion for Q1 2026.

• In Q1 2026, Common Equity fell 1.27% year-over-year to $49.0 billion; the TTM figure through Jan 2026 stood at $49.0 billion (down 1.27% YoY), while the FY2025 annual figure was $48.0 billion, down 4.75% from the prior year.
• Common Equity came in at $49.0 billion for Q1 2026 at Medtronic, roughly flat from $48.9 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $52.8 billion in Q3 2022 to a low of $48.0 billion in Q2 2025.
• A 5-year average of $50.6 billion and a median of $51.4 billion in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity gained 3.5% in 2022 and declined 6.24% in 2024, its largest moves.
• Medtronic's Common Equity stood at $52.1 billion in 2022, then retreated by 0.79% to $51.6 billion in 2023, then fell by 5.68% to $48.7 billion in 2024, then rose by 0.29% to $48.9 billion in 2025, then gained by 0.26% to $49.0 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $49.0 billion, $48.9 billion, and $48.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison